UC’s top revenue-generating inventions
The University of California received more than $118 million in royalty and fee payments in 2014. Here are the top revenue-generating inventions:
Royalty and fee income (in thousands)
1. Prostate cancer drug, UCLA: $33,353
2. Hepatitis-B vaccine, UC San Francisco: $8,766
3. EGF receptor antibodies, UC San Diego: $6,754
4. Bovine growth hormone, UC San Francisco: $5,747
5. Chromosome painting, Lawrence Livermore National Laboratory: $3,571
Total royalty and fee income, 2014: $118,243
Source: University of California
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
